KMPH - KemPharm GAAP EPS of -$0.19 misses by $0.03 revenue of $2.87M misses by $0.14M November, 09 2022 04:19 PM KemPharm Inc KemPharm press release ( NASDAQ: KMPH ): Q3 GAAP EPS of -$0.19 misses by $0.03 . Revenue of $2.87M (+45.7% Y/Y) misses by $0.14M . For further details see: KemPharm GAAP EPS of -$0.19 misses by $0.03, revenue of $2.87M misses by $0.14M